About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,767 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,767 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4001-4020 of 4,767 trials

RecruitingSurveillance of Pancreatic Health After Diabetes DiagnosisThe goal of this interventional study is to evaluate if the novel diagnostic blood test, called Avantect can early detect pancreatic cancer in patients diagnosed with type 2…NCT06803771·Sandbach, Cheshire and 30 others CompletedBevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic CancerThis phase II trial is to see if combining gemcitabine with bevacizumab works in treating patients who have advanced pancreatic cancer.NCT00028834·Chicago, Illinois

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

TerminatedA Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic CancerStudy Hypothesis: To estimate time to recurrence in pancreatic cancer patients treated with adjuvant erlotinib and gemcitabine.NCT00336700·Pittsburgh, Pennsylvania

CompletedThe Pre-operative Pathway in Pancreatic Head Malignancy-assessment of the Diagnostic Accuracy of Staging CT ScanOur aim is to assess the ability of scans to distinguish the organ of origin of pancreatic head malignant tumours and to predict the resectability based on the preoperative…NCT02296736·Plymouth, Devon

UnknownBiliary Tissue Sampling Using a Cytology Brush or the GIUM CatheterIntroduction In patients with a biliary obstruction, tissue is acquired immediately before drainage during endoscopic retrograde cholangio-pancreatography (ERCP).NCT00160836·Buenos Aires and 2 others

RecruitingDOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic CancerThe goal of this clinical trial is to estimate the antitumor response of mFOLFIRINOX + Dostarlimab + oral HD vitamin D3 in patients with non-pretreated histologically confirmed…NCT06757244·Marseille and 4 others

SuspendedRCT of Mobile Apps & FitBit v. Usual CareThis is a randomized clinical trial to evaluate the use of mobile devices in preventing readmission in patients undergoing major GI cancer operations.NCT03623464·New York, New York

RecruitingPGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.This study will collect patient PRO (physical strength, pain, defecation, appetite, weight, etc.) data through the APP, use corpus collection cards, facial photography and other…NCT07167264·Shanghai, Shanghai Municipality

RecruitingComparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion TrackerPhysical activity is an important aspect of cancer therapy but correct measurement of physical activity is difficult.NCT05501379·Greifswald

CompletedRegistry of Pancreatic Exocrine Insufficiency: Enzyme Dose Requirements and Outcomes in Pancreatic Exocrine Insufficiency Across AetiologiesEURO-PEI is a multicentre, observational registry conducted at eight specialist pancreatic centres in Spain, Hungary, France, Italy, and the United Kingdom.NCT05450627·Santiago de Compostela, A Coruña

UnknownEvaluation of Difficulty Score for Robotic PancreatoduodenectomyRobotic pancreatoduodenectomy is the most complex surgery for a general surgeon and consequently a pancreatic surgeon can aspire to.NCT04662346·Pisa and 1 other

CompletedEarly (4 Days) Versus Standard Drainage of the Abdominal Cavity After PancreaticoduodenectomyAround two thousand pancreaticoduodenectomy (PD) are performed each year in France.NCT01368094·Amiens, Picardie and 4 others

UnknownThe Effect of ERAS on Pancreaticoduodenectomy (v2.0)Enhanced Recovery After Surgery (ERAS) is not a program that aims to reduce postoperative hospital stay, but the multimodal strategies that aim to attenuate the loss of, and…NCT06009224·Seoul

UnknownA Study to Assess PV-10 Chemoablation of Cancer of the LiverThis open-label study will evaluate the safety, tolerability, pharmacokinetics and effect on tumor growth following a single intralesional injection of PV-10 in subjects with…NCT00986661·San Diego, California and 4 others

CompletedPancreatic Anastomosis After DuodenopancreatectomyA national, multicenter, randomized, prospective, parallel group clinical study to evaluate two therapeutic strategies (invaginating pancreatogastric anastomosis versus Blumgart…NCT04462354·Valencia

CompletedInvestigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA TxTo test the ability of new imaging techniques to monitor and predict response of pancreatic cancer to radiation and/or chemotherapy.NCT00767273·Stanford, California

RecruitingmFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic CancerThe purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus radiotherapy to Patients with CA19-9-normal Advanced Pancreatic Cancer.NCT06149689·Shanghai

RecruitingLiver Embolization Approaches for Tumor ManagementThe goal of this evaluate short, medium and long term outcome of the different embolization techniques in patients with primary and secondary hepatic tumors.NCT05714124·Milan

CompletedIsolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver MetastasesRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different ways may kill more tumor cells.NCT00019786·Bethesda, Maryland

CompletedPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsRATIONALE: Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00667641·New Brunswick, New Jersey

PreviousPage 201 of 239Next